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Abstract 
Rhazya stricta is a unique medicinal plant source for many indole alkaloids, non-alkaloids, flavonoids, triterpenes and 
other unknown molecules with tremendous potential for therapeutic applications against many diseases. In the pre-
sent article, we generated computational data on predictive properties and activity across two key therapeutic areas 
of cancer and obesity, and corresponding cheminformatics studies were carried out to examine druggable properties 
of these alkaloids. Computed physiochemical properties of the 78 indole alkaloids from R. stricta plant using industry-
standard scientific molecular modeling software and their predictive anti-cancer activities from reliable web-source 
technologies indicate their plausible therapeutic applications. Their predictive ADME properties are further indicative 
of their drug-like-ness. We believe that the top-ranked molecules with anti-cancer activity are clearly amenable to 
chemical modifications for creating potent, safe and efficacious compounds with the feasibility of generating new 
chemical entities after pre-clinical and clinical studies.
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Background
Rhazya stricta Decsne (Apocynaceae family), a traditional 
herbal medicinal plant from Western and South Asia, has 
been shown to have multiple pharmacological effects due 
to the presence of over 100 alkaloids [1–3]. The chemi-
cal constituents of this plant (R. stricta) may possess 
biological activities of antifungal, antimicrobial, antioxi-
dant, CNS, hypertension, metabolic, and inflammatory 
disorders. Rhazimine, an alkaloid isolated from R. stricta 
leaves, was shown to affect arachidonic acid metabo-
lism in human blood [4]. This alkaloid was shown to be 
a dual and selective inhibitor of platelet activating factor 
(PAF)-induced platelet aggregation and arachidonic acid 
metabolism. Other effects of the lyophilized extract of 
R. stricta include an antispasmodic effect in rat muscles 
[5]. In another study, antioxidant effects were observed at 
higher doses, and it reduced the hepatic and renal con-
centrations of glutathione (GSH) and increased the ascor-
bic acid levels, whereas the degree of lipid peroxidation 
was reduced [6]. A recent study has shown that the basic 
alkaloid fraction from R. stricta significantly induces one 
of the chemopreventive enzyme-Nqo 1, through an Nrf 
2-dependent mechanism, thereby establishing its role 
as an anti-tumor agent [7]. In another pharmacological 
study, the biochemical parameters including blood lipid 
profile concentrations, liver enzyme activities and kidney 
functions were analyzed in rats [8]. It was also found that 
aqueous extract of R. stricta and indole alkaloids caused 
a significant increase in serum adiponectin levels and 
resulted in significant improvements in insulin resistance 
[9]. In another follow up study, we observed indole-alka-
loids of R. stricta improved not only the lipid profile and 
liver function but also led to improvements in the insulin 
levels in rats, most likely via modulating insulin resist-
ance [10]. Indole-alkaloids of R. stricta had been reported 
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to have anticancer properties [11]. Other studies by our 
departmental colleagues showed that alkaloid extract of 
R. stricta leaves inhibited proliferation, colony formation 
and anchorage-independent growth in various cancer cell 
lines such as colon cancer, breast cancer and lung cancer 
[12–14].
Understanding the chemical structure, physiochemi-
cal, and chemical-informatic properties of these natural 
product compounds will give clues for further modifi-
cations required in their structures responsible for their 
biological activities. Even though, there have been about 
100 chemical entities of indole-based alkaloid constitu-
ents of R. stricta which have been reported but their 
chemical structures are yet to be clustered and identified, 
and moreover the pharmacological application of any one 
of these constituents towards human health is yet to be 
identified. Understanding qualitative correlation of struc-
tures to their chemical druggability, IP potential, and their 
applicability towards a therapeutic area would be worth 
exploring prior to pre-clinical studies. Availability of this 
plant (R. stricta), thus its phytochemical constituents 
largely in Arabian and South Asian region makes it worth 
studying through computational, synthetic, and biologi-
cal view point. Indole based alkaloids such as vinblastine 
and vincristine are well known for their anti-cancer prop-
erties. From systematically generated informatics data 
analysis, one would be able to evaluate the physiochemi-
cal properties of the potential therapeutic compounds. 
These promising molecules which have “desirable phar-
macophores” may provide obvious extension to a better 
targeted therapeutic benefit. Conventional drugs obey 
set of rules such as Lipinski’s Rule-of-Five (RO5) [15], 
wherein all orally administered molecules need to have 
certain physiochemical properties. Calculation of these 
cheminformatic properties has thus become essential for 
all projects of new drug discovery which go through oral 
route of administration. Along with RO5, the new mol-
ecules also have to adhere to certain parameters which 
yield favorable ADMET outcome of an oral drug. We 
further evaluated these molecules for therapeutic activ-
ity, including anticancer, anti-obesity, anti-inflammatory, 
and anti-bacterial properties. Although these predictions 
are indicative only, the value of predictions in various tar-
get classes and therapeutic areas would be very useful for 
future experimental studies. Moreover, their metabolic 
fate with key enzymes such as P450’s is also predicted for 
probable drug–drug and drug-target (P450) interactions 
(reviewed in [16, 17]).
Methods
For prediction of various therapeutic potential of these 
molecules, commercially and publicly available technolo-
gies as below were utilized.
a. PharmaExpert (http://www.pharmaexpert.ru)—PASS 
[18]






Schrodinger [22], a scientific software that predicts 
drug-like properties and liabilities (viz. HERG and CNS), 
and ACD/Labs [23] for physiochemical and cheminfor-
matics studies were utilized. Details of the molecules, 
names, structures were obtained from the literature, 
commercial sources, and knowledge-based web sources. 
Tables  1 and 2 gives the details of these molecules 
together with their 2D SMILES notation, respectively.
Results and discussion
Physiochemical and cheminformatic studies
ACD/Laboratories informatics modules generated phys-
iochemical and cheminformatics data of R. stricta indole 
and non-indole alkaloids. For all the selected 78 mol-
ecules in this study, it was observed that less than 20% 
of the molecules are having molecular weights  >450, 
while most molecules range around 300–350, indicating 
their viability for additional medicinal chemistry amena-
ble nature. Most of these molecules are also moderately 
to highly soluble—mainly due to the high value of pKa 
(leading to solubility at neutral pH). Additionally, many 
of these indole/non-indole molecules are also less lipo-
philic (~75% of them have logP ~3 to 4). Alkaloids that 
violate Lipinski’s Rule-of-5 are either due to molecular 
weight or logP, are tetrahydrosecamine; presecamine; 
beta-sitosterol; ursolic acid; stigmasterol; oleanolic 
acid; secamine; bis-strictidine; 3,14-dehydrorhazigine; 
16-hydroxyrhazisidine; rhazisidine; rhazigine; dihydrose-
camine; dihydropresecamine; tetrahydropresecamine; 
decarbomethoxy-15,17-tetrahydrosecodine;16s,16′-
decarboxytetrahydro-secamine. Figures  1 and 2 give 
the plots of molecular weight and LogP (lipophilicity) 
of individual compounds, accordingly. Since most of the 
molecules have a basic nitrogen and sometimes, may be 
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Table 1 Chemical structures and names of Rhazya stricta compounds
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more than one, leading to a larger pKa at physiological 
pH—thus leading most molecules are highly to moder-
ately soluble at physiological pH. Very few compounds 
and non-indole alkaloids have no basic nitrogen leading 
to highly insoluble compounds in water at physiologi-
cal pH. As the acidity goes up (leading towards pH 1), 
most compounds become largely soluble. A qualita-
tive and quantitative (computational) estimate of solu-
bility of these compounds are given in Tables  3 and 4, 
respectively.
QUIKPROP calculations
Predicted Quikprop properties for potential cardiac lia-
bilities such as HERG, and CNS liabilities (Blood–Brain-
Barrier) and drug-like nature of these molecules indicate 
that many of these molecules are well within the bounda-
ries of accepted hit-, and lead-like nature. QuikProp cal-
culations were performed using Schrodinger’s Maestro 
for various alkaloids of R. stricta. These predictions not 
only give Rule-of-5 data, but also predict the cardiotox-
icity predictions (HERG) and CNS penetration poten-
tial (logBBB) properties. More importantly, it also gives 
the prediction regarding cell-permeability (Caco2). All 
these models are well validated in literature, and most 
of them perform well within the reproducible results for 
training datasets. Results indicate that many of the mol-
ecules have decent permeation through Caco2 cell lines 
(>300), while the polar surface area (PSA) is not too high 
(>120) for oral absorption. For HERG toxicity predic-
tion, below −5 (i.e. −6, −7 etc.) is not considered to be 
safe. Hence, those molecules whose logHERG values are 
well below -5 (such as geissoschizine, presecamine, tet-
rahydrosecamine) may exhibit cardioliability. The human 
intestinal absorption is also predicted, and it appears for 
most molecules, these values are larger. Any %HIA pre-
diction >90% is expected to be well absorbed, and their 
polar surface area (PSA) is also a direct correlation to 
it. Those molecules whose molecular weights are  >500 
exhibit rule-of-5 violation and this violation goes beyond 
1 to a maximum of 3. Those molecules appear structur-
ally much larger and like dimers. Table 5 gives computed 
Quikprop computed values of various alkaloids of R. 
stricta. Table 6 also indicates various other physiochemi-
cal parameters including surface tension, parachor etc. of 
R. stricta indole and non-indole analogs.
Predicted therapeutic area applications
PASS—prediction of activity spectra for substances
This web-based predictive server from Way2Drug, has 
variety of annotators of substances for their probability 
Table 1 continued
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Table 2 SMILES codes for Rhazya stricta compounds











































M37 Ursolic acid CC1CCC2(CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(O)=O
M38 Stigmasterol CCC(\C=C\C(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C
M39 Olenaolic acid CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1)C(O)=O
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of active or inactive towards few targets. Out of all ser-
vices and products of them, we utilized PASS method 
of predictions. More than 100 activities are predicted 
with their probability of activities and in-activities. Some 
of them include kinase inhibitors, GPCR antagonists, 
and some specific targets like adrenergic receptors, and 
Table 2 continued
MOL ID Name SMILES code




M48 Bis-strictidine CCC1=C2C3CC4(CCN2CCC1)C5C=CC=CC5 N=C4C6CC7(CCN8CCCC(=C68)
CC)C3=NC9=C7C=CC=C9




M51 Rhazisidine CCC1=CCCN(CCC2=C3C(CC4C([N]3C5=C2C=CC=C5)C6=C(CC)C=C CN6C
CC7=C4[NH]C8=C7C=CC=C8)C(=O)OC)C1
M52 Isorhazicine COC(=O)C12C(CC3(C(O)NC4=C3C=CC=C4)C1=O)N5CCC2\C(C5)=C\C
M53 Rhazigine CCC1=CCCN(CCC2=C([NH]C3=C2C=CC=C3)C4CCC(=C5NC6=C(C=CC=C6) C45C
CN7CCC=C(CC)C7)C(=O)OC)C1
M54 Strictisidine COC(=O)C12C3CC4(C1=O)C(=NC5=C4C=CC=C5)C6CC2\C(CN36)=C\C
M55 Strictamine-N-oxide COC(=O)C1C\2CC3C4=NC5=CC=CC=C5C14CC[N +]3([O-])CC2=C/C
M56 Strictigine CCC1=C2CCN(CCC23C(=NC4=CC=CC=C34)C=C)C1






M63 Dihydrosecamine CCC1CCCN(CCC2=C([NH]C3=C2C=CC=C3)C4(CCC(C(=O)OC)C5=C (CCN6CC
C=C(CC)C6)C7=CC=CC=C7[N]45)C(=O)OC)C1
M64 Dihydropresecamine CCC1CCCN(CCC2=C([NH]C3=CC=CC=C23)OC(=O)C4CCC(=C5 N© C6=CC=C
C=C6C45CCN7CCC=C(CC)C7)C(=O)OC)C1
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their kinase inhibitors. We considered the probability of 
active (Pa)  >0.3 (i.e.  >30%), and should be greater than 
probability of inactive (Pi). Given these conditions, we 
observed many alkaloids have indicated Pa  >0.8 in cer-
tain conditions (such as, anthrine has predicted Pa at 90% 
towards β-adrenergic receptor kinase inhibitor, 5-HTA 
release stimulant). Majority of them also is predicted to 
be substrate to CYP3A4 and CYP2D6 indicating their 
metabolic instability (Pa ~ 0.5, 0.4, respectively). Several 
such predictions for all 78 alkaloids has been computed—
leaving predictions to be validated, experimentally. 
Similarly, dihydrocorynantheol and corynantheol were 
also predicted to be 5-HT release stimulants, and have 
been projected to be chemosensitizers. Eburnamenine 
is predicted to be a Nootropic agent at 90% Pa, while 
eburnamine is predicted to be a CNS (anti-depressant 
and mood disorder management agent at  >96% Pa). 
Strictosidine is predicted to be an antiprotozoal at 86% 
Pa, β-sitosterol is anti-hypercholesterolemic agent with 
Pa ~98%, rhazidigenine (rhazidine) is an antidyskinetic at 
60% Pa, secamine is a H1F1A expression inhibitor at 83% 
Pa (but a non-pharmaceutically acceptable molecule due 
to high MW and many RO5 violations). A similar obser-
vations is also made for 16-hydrorhazisidine (72% Pa for 
H1F1A expression inhibitor). Strictamine is predicted 
to be gluconate 2-dehydrogenase acceptor with 70% Pa, 
and 1,2-dehydroaspidospermine (which is a small mol-
ecule) has been predicted to be analeptic with 77% Pa. 
Dihydrosecamine is predicted to be a H1F1A expres-
sion inhibitor with 77% Pa, and rhazidigenine-N-oxide 
is predicted to be a cognition disorder agent with 64% 
Pa. Decarbomethoxy-15,20,16,17-tetrahydrosecodine 
Fig. 1 Variation of Molecular weight of compounds of Rhazya stricta
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is a small molecule with ~70% Pa for antidyskinetic and 
antineuronic agent, 1,2-dehydrospidospermidine-N-
oxide is predicted to be 87% as analeptic.
Anticancer activity through CDRUG
This set of predictions using the structures and SMILES 
codes of the alkaloids, annotates the anti-cancer activ-
ity by predicting “Mean logGI50”. Most molecules that 
have Mean LogGI50 values lower than −5 are consid-
ered to have anti-cancer activity. It is interesting to know 
that all the molecules of R. stricta alkaloids (indole/non-
indole) have predicted mean logGI50 values ranging 
between −4.95 and −6.50—indicating they all may have 
anti-cancer activities. There are about 10 compounds 
that have predicted logGI50 values less than −6, which 
indicate strong anti-cancer activity. Table  7 shows the 
predicted mean LogGI50 values of all the compounds 
considered in the present study.
SuperPred—predicted target interactions
From this server studies on R. stricta alkaloids, we 
observed that many of these molecules may interact with 
CYP2D6 or CYP3A4 as substrates. The indication of 
these results mean that their target may be unknown, but 
they do modify the drug metabolism, and affect drug–
drug interactions.
Fig. 2 Variation of LogP of compounds of Rhazya stricta
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Table 4 Predicted solubility and pKa (acid and base) of various Rhazya stricta compounds
ID Name Solubility LogSW/LogSw LogSw/pH pKa (acid) pKa (base)
1 Akuammidine Soluble −3.32 8.85 14.79 6.88
2 Antirhine Soluble −4.08 9.49 14.72 9.24
3 3-Epi-antirhine Soluble −4.08 9.49 14.72 9.24
4 Aspidosespermidine Soluble −2.34 10.82 9.94
5 Condylocarpine Soluble −3.13 9.36 7.98
6 Dihydrocorynantheol Soluble −4.04 9.57 15.08 9.37
7 Eburnamenine Soluble −4.6 8.92 8.61
8 Eburnamine Soluble −4.39 9.15 14.3
9 Eburnamonine Soluble −4.4 8.82 8.13
10 Geissoschizine Insoluble −3.64 6.59 4.73 8.25
11 Isositsirikine Soluble −4.1 9.16 14.29 8.49
12 16-Epi-Z-isositsirikine Soluble −4.1 9.16 14.29 8.49
13 leuconolam Soluble −1.83 6.71 11.76 0.36
14 Rhazinilam Highly insoluble −4.47 7 1.21
15 Tetrahydrosecamine Soluble −3.67 8.07 17.43 9.4
16 Presecamine Soluble −5.27 8.48 15.79 8.54
17 Sewarine Soluble −2.98 9.17 11.08 1.95
18 Stemmadenine Soluble −3.63 9.21 11.84 8.08
19 Strictamine Insoluble −4.47 7.7 5.74
20 Strictosamide Soluble −3.26 7 12.79 −1.64
21 Strictosidine Soluble −2.73 10.83 12.81 10.62
22 Tabersonine Soluble −2.99 9.25 7.64
23 Tetrahydroalstonine Soluble −4.4 8.89 18.03 8.27
24 Vallesiachotamine Highly insoluble −5.21 7.45 17.46 6.08
25 Aspidospermiose Soluble −0.19 9.81 10.11 9.88
26 Bhimberine Soluble −4.1 9.16 14.29 8.49
27 Bhimbhrine N-oxide Soluble 0.4 9.66 14.2 5.17
28 Rhazimine Soluble −2.89 8.9 6.51
29 Rhazimanine Soluble −4.1 9.16 14.29 8.49
30 Rhazicine Soluble −1.6 8.94 11.3 6.36
31 Leepacine Soluble −1.84 9.43 6.69
32 2-Methoxy-1,2-dihydrorhazimine Soluble −2.18 9.15 6.3
33 HR-1 Soluble 0.43 8.55 12.69 4.6
34 Vincanicine Soluble −2.67 9.67 8.16
35 Rhazinaline Insoluble −4.14 7.47 5.03
36 Beta-sitosterol Highly insoluble −7.6 7 15.03
37 Ursolic acid Highly insoluble −6 6.01 15.18
38 Stigmasterol Highly insoluble −7.52 7 15.03
39 Oleanolic acid Highly insoluble −6.02 6.04 15.18
40 Rhazidigenine Soluble −3.2 9.92 12.43 8.82
41 N-methylleuconolam Soluble −1.52 6.55 11.62 0.09
42 (+)-Quebrachamine Soluble −4.15 9.55 17.84 9.74
43 Polyneuridine Soluble −3.2 8.46 17.19 6.11
44 (+)-Vincadiformine Soluble −3.06 10.04 9.33
45 (−)-Vincadifformine Soluble −3.06 10.04 9.33
46 Secamine Soluble −5.12 8.22 17.34 8.71
47 Vincadine Soluble −4.23 9.28 16.98 9.11
48 Bis-strictidine Insoluble −6.11 7.79 7.57
49 3,14-Dehydrorhazigine Highly insoluble −5.89 8.12 10.62
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SwissTarget prediction
While predictions from this web-server may suggest each 
molecule have certain target activity, they almost corre-
late well with the PASS server prediction—which gives 
additional probability of prediction for each molecule to 
be active or inactive against the target of interest.
Overall from the calculated cheminformatics stud-
ies and web-server predictions, we understand that 
few molecules like anthrine, condylocarpine, dihydro-
corynantheol etc. have predicted GIC50 values in sub 
µM concentrations, while they also have predicted drug–
drug activity towards CYP3A4, and CYP2D6 enzymes. 
Solubility solubility classifications, LogSW/LogSw ratio of solubility in water vs. intrinsic solubility, LogSw/pH solubility in water at pH 7.0, pKa (acid) pKa in acidic pH, 
pKa(base) pKa in basic pH
Table 4 continued
ID Name Solubility LogSW/LogSw LogSw/pH pKa (acid) pKa (base)
50 16-Hydrorhazisidine Soluble −5.05 8.28 13.98 10.8
51 Rhazisidine Insoluble −5.56 8.2 17.47 8.76
52 Isorhazicine Soluble −1.6 8.94 11.3 6.36
53 Rhazigine Soluble −4.44 7.7 17.45 8.89
54 Strictisidine Soluble −2.18 8.18 4.27
55 Strictamine-N-oxide Soluble −0.67 8.73 4.17
56 Strictigine Soluble −4.07 8.83 7.71
57 Strictine Highly insoluble −4.79 7.36 5.41
58 Stricticine Soluble −3.68 9.33 8.43
59 Strictalamine Insoluble −3.94 8.04 5.87
60 1,2-Dehydroaspidospermidine(eburenine) Soluble −2.84 10.23 9.38
61 Tetrahydrosecodine Soluble −3.85 9.67 16.75 9.33
62 Dihydrosecodine Soluble −3.84 9.44 16.66 8.73
63 Dihydrosecamine Soluble −4.61 8.3 17.43 9.4
64 Dihydropresecamine Soluble −4.78 8.28 15.88 9.16
65 Tetrahydropresecamine Soluble −3.89 8.23 15.88 9.65
66 Rhazinol Insoluble −4.1 8.25 14.53 6.3
67 Rhazimol Insoluble −4.24 7.67 14.53 5.45
68 Rhazidigenine-N-oxide Soluble 0.5 8.35 11.98 49.2
69 (−)16R,21R-omethyleburnamine Soluble −4.93 8.73 8.66
70 Decarbomethoxy-15,20,16,17-tetrahydros Soluble −3.79 9.81 17.83 9.46
71 1-2-Dehydroasidospermidine-N-oxide Soluble −1.2 8.95 4.82
72 Rhazizine Soluble −2.61 9.2 7.31
73 15-Hydroxyvincadifformine Soluble −2.36 9.88 14.4 8.46
74 Dihydroeburnamenine Soluble −4.72 9.06 9.41
75 16s,16’-Decarboxytetra-hydrosecamine Soluble −3.5 7.88 17.43 9.4
76 Nor-C-fluorocurarine Soluble −2.4 9.8 8.14
77 Strictibine Insoluble −3.7 7 1.06
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Table 6 Surface related and ring-related properties of Rhazya stricta compounds
ID Name CR NR NOR HetR #R Para Ind.Ref Sur.Ten Density Polar.
1 Akuammidine 0.81 0.08 0.19 0.19 6 743.43 1.68 65.34 1.35 39.32
2 Antirhine 0.86 0.09 0.14 0.14 4 676.25 1.65 56.53 1.2 35.76
3 3-Epi-antirhine 0.86 0.09 0.14 0.14 4 676.25 1.65 56.53 1.2 35.76
4 Aspidosespermidine 0.9 0.1 0.1 0.1 5 647.87 1.63 50.04 1.16 34.2
5 Condylocarpine 0.83 0.08 0.17 0.17 5 681.18 1.66 56.36 1.3 36.43
6 Dihydrocorynantheol 0.86 0.09 0.14 0.14 4 687.1 1.64 55.86 1.19 35.85
7 Eburnamenine 0.9 0.1 0.1 0.1 5 589.57 1.7 49.78 1.25 33.94
8 Eburnamine 0.86 0.09 0.14 0.14 5 595.24 1.72 54.34 1.35 34.28
9 Eburnamonine 0.86 0.09 0.14 0.14 5 595.24 1.72 54.34 1.34 34.28
10 Geissoschizine 0.81 0.08 0.19 0.19 4 762.54 1.66 61.38 1.29 40.01
11 Isositsirikine 0.81 0.08 0.19 0.19 4 776.63 1.64 59.3 1.27 40.13
12 16-Epi-Z-isositsirikine 0.81 0.08 0.19 0.19 4 776.63 1.64 59.3 1.27 40.13
13 Leuconolam 0.79 0.08 0.21 0.21 4 692.66 1.65 63.34 1.33 35.61
14 Rhazinilam 0.86 0.09 0.14 0.14 4 635.67 1.65 47.86 1.22 34.93
15 Tetrahydrosecamine 0.84 0.08 0.16 0.16 7 1449.04 1.63 46.81 1.23 78.28
16 Presecamine 0.84 0.08 0.16 0.16 7 1516.34 1.65 60.13 1.24 78.73
17 Sewarine 0.8 0.08 0.2 0.2 5 696.4 1.69 64.76 1.38 37.04
18 Stemmadenine 0.81 0.08 0.19 0.19 5 729.69 1.64 47.88 1.28 39.55
19 Strictamine 0.83 0.08 0.17 0.17 5 631.14 1.71 52.17 1.37 36.23
20 Strictosamide 0.72 0.06 0.28 0.28 6 986.67 1.72 84.28 1.53 50.75
21 Strictosidine 0.71 0.05 0.29 0.29 5 1078.5 1.66 74.07 1.44 54
22 Tabersonine 0.84 0.08 0.16 0.16 5 723.31 1.65 55.72 1.27 38.37
23 Tetrahydroalstonine 0.81 0.08 0.19 0.19 5 748.43 1.66 58.69 1.3 39.39
24 Vallesiachotamine 0.81 0.08 0.19 0.19 4 754.43 1.65 59.07 1.29 39.54
25 Aspidospermiose 0.77 0.06 0.23 0.23 6 885.22 1.68 74 1.42 45.19
26 Bhimberine 0.81 0.08 0.19 0.19 4 776.63 1.64 59.3 1.27 40.13
27 Bhimbhrine N-oxide 0.78 0.07 0.22 0.22 4  45.12
28 Rhazimine 0.81 0.08 0.19 0.19 6 690.3 1.69 54.96 1.38 38.6
29 Rhazimanine 0.81 0.08 0.19 0.19 4 776.63 1.64 59.3 1.27 40.13
30 Rhazicine 0.78 0.07 0.22 0.22 6 757.54 1.66 64.83 1.38 39.13
31 Leepacine 0.81 0.08 0.19 0.19 7 709 1.68 63.18 1.39 37.7
32 2-Methoxy-1,2-dihydrorhazimine 0.79 0.07 0.21 0.21 6 800.93 1.63 56.72 1.31 41.05
33 HR-1 0.78 0.07 0.22 0.22 4
34 Vincanicine 0.83 0.08 0.17 0.17 5 683.12 1.66 57.29 1.3 36.52
35 Rhazinaline 0.81 0.08 0.19 0.19 5 690.3 1.69 54.96 1.38 38.6
36 Beta-sitosterol 0.97 0 0.03 0.03 4 1051.02 1.52 37.64 0.98 51.22
37 Ursolic acid 0.91 0 0.09 0.09 5 1076.71 1.56 45 1.1 52.93
38 Stigmasterol 0.97 0 0.03 0.03 4 1038.63 1.53 38.25 0.99 51.19
39 Oleanolic acid 0.91 0 0.09 0.09 5 1077.07 1.56 45.41 1.1 52.95
40 Rhazidigenine 0.86 0.09 0.14 0.14 4 650.55 1.64 48.09 1.21 35.15
41 N-methylleuconolam 0.8 0.08 0.2 0.2 4 730.79 1.65 61.9 1.31 37.53
42 (+)-Quebrachamine 0.9 0.1 0.1 0.1 4 672.49 1.62 50.29 1.12 35.27
43 Polyneuridine 0.81 0.08 0.19 0.19 6 735.31 1.67 62.83 1.34 38.85
44 (+)-Vincadiformine 0.84 0.08 0.16 0.16 5 735.7 1.63 53.98 1.25 38.4
45 (-)-Vincadifformine 0.84 0.08 0.16 0.16 5 735.7 1.63 53.98 1.25 38.4
46 Secamine 0.84 0.08 0.16 0.16 7 1449.04 1.63 46.81 1.22 78.28
47 Vincadine 0.84 0.08 0.16 0.16 4 776.11 1.61 52.34 1.18 39.67
48 Bis-strictidine 0.9 0.1 0.1 0.1 9 1150.88 1.73 52.95 1.31 67.18
49 3,14-Dehydrorhazigine 0.87 0.09 0.13 0.13 7 1340.13 1.64 46.53 1.2 73.46
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Most molecules turnout to be modulators of membrane 
receptor ligands while some have predicted cholinest-
erase, CNS (5HT2x), adenosine (A2A/A2B) activity. 
Moreover, all molecules have predicted activity towards 
certain targets (Pa > 30%).
Conclusions
Table  8 indicates the top 10-best naturally occurring 
indole alkaloids of R. stricta that were predicted to be 
having decent anti-cancer activity and other good physi-
ochemical properties together with cheminformatics 
Table 6 continued
ID Name CR NR NOR HetR #R Para Ind.Ref Sur.Ten Density Polar.
50 16-Hydrorhazisidine 0.85 0.09 0.15 0.15 7 1345.28 1.65 48.02 1.24 73.94
51 Rhazisidine 0.87 0.09 0.13 0.13 8 1284.82 1.68 49.12 1.27 72.59
52 Isorhazicine 0.78 0.07 0.22 0.22 6 757.54 1.66 64.83 1.38 39.13
53 Rhazigine 0.87 0.09 0.13 0.13 7 1412.62 1.65 58.36 1.21 74.23
54 Strictisidine 0.81 0.08 0.19 0.19 7 635.5 1.78 63.63 1.55 37.59
55 Strictamine-N-oxide 0.8 0.08 0.2 0.2 5
56 Strictigine 0.9 0.1 0.1 0.1 5 622.49 1.63 42.69 1.14 34.52
57 Strictine 0.8 0.08 0.2 0.2 5 636.29 1.73 55.79 1.44 36.71
58 Stricticine 0.8 0.08 0.2 0.2 6 682.41 1.68 61.46 1.39 36.43
59 Strictalamine 0.86 0.09 0.14 0.14 5 580.88 1.74 55.15 1.37 33.92
60 1,2-Dehydroaspidospermidine 0.9 0.1 0.1 0.1 5 590.09 1.7 50.6 1.27 33.8
61 Tetrahydrosecodine 0.84 0.08 0.16 0.16 3 807.26 1.56 42.67 1.08 40.69
62 Dihydrosecodine 0.84 0.08 0.16 0.16 3 793.18 1.58 44.47 1.11 40.53
63 Dihydrosecamine 0.84 0.08 0.16 0.16 7 1449.04 1.63 46.81 1.23 78.28
64 Dihydropresecamine 0.84 0.08 0.16 0.16 7 1530.43 1.64 59.1 1.23 78.84
65 Tetrahydropresecamine 0.84 0.08 0.16 0.16 7 1544.52 1.63 58.11 1.22 78.96
66 Rhazinol 0.86 0.09 0.14 0.14 5 580.88 1.74 55.15 1.38 33.92
67 Rhazimol 0.81 0.08 0.19 0.19 5 690.3 1.69 54.96 1.39 38.6
68 Rhazidigenine-N-oxide 0.83 0.09 0.17 0.17 4
69 (-)16R,21R-omethyleburnamine 0.87 0.09 0.13 0.13 5 639.83 1.67 47.55 1.27 36.25
70 Decarbomethoxy-15,20,16,17-tetrahydros 0.9 0.1 0.1 0.1 3 703.65 1.57 40.68 1.02 36.31
71 1-2-Dehydroasidospermidine-N-oxide 0.86 0.09 0.14 0.14 5
72 Rhazizine 0.78 0.07 0.22 0.22 6 744.62 1.67 62.43 1.39 39.14
73 15-Hydroxyvincadifformine 0.81 0.08 0.19 0.19 5 750.68 1.65 60.33 1.32 39
74 Dihydroeburnamenine 0.9 0.1 0.1 0.1 5 589.57 1.7 49.78 1.26 33.94
75 16s,16′-Decarboxytetra-hydrosecamine 0.87 0.09 0.13 0.13 7 1339.61 1.64 46.2 1.21 73.6
76 Nor-C-fluorocurarine 0.86 0.09 0.14 0.14 5 624.5 1.68 57.83 1.29 33.99
77 Strictibine 0.81 0.06 0.19 0.19 3 442.8 1.65 51.74 1.29 23.76
Ind Ref refractive index, Para parachor, Sur ten surface tension, Polar polarizability, #R number of rings, CR ratio of carbons, NR ratio of nitrogens, NOR ratio of oxygens, 
HetR ratio of heteroatoms
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Table 7 Predicted mean LogGI50 of  Rhazya stricta com-
pounds whose values lower than  −6.0 are highlighted 
in italics may exhibit anti-cancer activity





































M37 Ursolic acid −5.124
M38 Stigmasterol −5.918
M39 Olenaolic acid −5.124
Table 7 continued
MOL ID Name Mean LogGI50 CDRUG
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properties—these molecules are antirhine, 3-epi-anti-
rhine, condylocarpine, eburnamine, eburnamonine, 
taberonine, ursolic acid, stigmasterol, olenaolic acid, 
(+)-vincadiformine, (−)-vincadiformine, (−)-16R,21R-
omethyleburmanine, 15-hydroxy-vincadifformine, and 
dihydroburnamenine.
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